Literature DB >> 22074718

A novel vascular clip design for the reliable induction of 2-kidney, 1-clip hypertension in the rat.

Stephen P Chelko1, Chad W Schmiedt, Tristan H Lewis, Stephen J Lewis, Tom P Robertson.   

Abstract

The 2-kidney, 1-clip (2K1C) model has provided many insights into the pathogenesis of renovascular hypertension. However, studies using the 2K1C model often report low success rates of hypertension, with typical success rates of just 40-60%. We hypothesized that these low success rates are due to fundamental design flaws in the clips traditionally used in 2K1C models. Specifically, the gap widths of traditional silver clips may not be maintained during investigator handling and these clips may also be easily dislodged from the renal artery following placement. Therefore, we designed and tested a novel vascular clip possessing design features to maintain both gap width and position around the renal artery. In this initial study, application of these new clips to the left renal artery produced reliable and consistent levels of hypertension in rats. Nine-day application of clips with gap widths of 0.27, 0.25, and 0.23 mm elicited higher mean arterial blood pressures of 112 ± 4, 121 ± 6, and 135 ± 7 mmHg, respectively (n = 8 for each group), than those of sham-operated controls (95 ± 2 mmHg, n = 8). Moreover, 8 out of 8 rats in each of the 0.23 and 0.25 mm 2K1C groups were hypertensive, whereas 7 out of 8 rats in the 0.27 mm 2K1C group were hypertensive. Plasma renin concentrations were also increased in all 2K1C groups compared with sham-operated controls. In summary, this novel clip design may help eliminate the large degree of unreliability commonly encountered with the 2K1C model.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22074718      PMCID: PMC3289428          DOI: 10.1152/japplphysiol.01015.2011

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  24 in total

1.  Renovascular hypertension using a modified two-kidney, one-clip approach in mice is not dependent on the α1 or α2 Na-K-ATPase ouabain-binding site.

Authors:  John N Lorenz; Valerie M Lasko; Michelle L Nieman; Thomas Damhoff; Vikram Prasad; William H Beierwaltes; Jerry B Lingrel
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-01

2.  The effect of a high sodium intake on the development of permanent nephrosclerotic hypertension; effect of nephrosclerotic hypertension of the granularity of the juxtaglomerular cells.

Authors:  L TOBIAN; J JANECEK; A TOMBOULIAN
Journal:  J Lab Clin Med       Date:  1959-06

3.  Occipital artery injections of 5-HT may directly activate the cell bodies of vagal and glossopharyngeal afferent cell bodies in the rat.

Authors:  P Lacolley; J R Owen; K Sandock; T H J Lewis; J N Bates; T P Robertson; S J Lewis
Journal:  Neuroscience       Date:  2006-10-09       Impact factor: 3.590

4.  Accuracy of implant placement using a CAD/CAM surgical guide: an in vitro study.

Authors:  Saeid Nokar; Elnaz Moslehifard; Tootiaii Bahman; Masoud Bayanzadeh; Farzad Nasirpouri; Arash Nokar
Journal:  Int J Oral Maxillofac Implants       Date:  2011 May-Jun       Impact factor: 2.804

5.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-02-23       Impact factor: 29.690

6.  A solid silver clip for induction of predictable levels of renal hypertension in the rat.

Authors:  F H Leenen; W de Jong
Journal:  J Appl Physiol       Date:  1971-07       Impact factor: 3.531

7.  Prevalence of primary and secondary hypertension: studies in a random population sample.

Authors:  G Berglund; O Andersson; L Wilhelmsen
Journal:  Br Med J       Date:  1976-09-04

8.  (Pro)renin receptor peptide inhibitor "handle-region" peptide does not affect hypertensive nephrosclerosis in Goldblatt rats.

Authors:  Dominik N Muller; Bernd Klanke; Sandra Feldt; Nada Cordasic; Andrea Hartner; Roland E Schmieder; Friedrich C Luft; Karl F Hilgers
Journal:  Hypertension       Date:  2008-01-22       Impact factor: 10.190

9.  Modulation of tubuloglomerular feedback by angiotensin II type 1 receptors during the development of Goldblatt hypertension.

Authors:  B Braam; L G Navar; K D Mitchell
Journal:  Hypertension       Date:  1995-06       Impact factor: 10.190

10.  Effect of antihypertensive treatment on the left ventricular isomyosin profile in one-clip, two kidney hypertensive rats.

Authors:  J C Dussaule; J B Michel; C Auzan; K Schwartz; P Corvol; J Menard
Journal:  J Pharmacol Exp Ther       Date:  1986-02       Impact factor: 4.030

View more
  10 in total

1.  Noninvasive measurement of renal blood flow by magnetic resonance imaging in rats.

Authors:  Cesar A Romero; Glauber Cabral; Robert A Knight; Guangliang Ding; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2017-10-04

Review 2.  Animal Models of Hypertension: A Scientific Statement From the American Heart Association.

Authors:  Lilach O Lerman; Theodore W Kurtz; Rhian M Touyz; David H Ellison; Alejandro R Chade; Steven D Crowley; David L Mattson; John J Mullins; Jeffrey Osborn; Alfonso Eirin; Jane F Reckelhoff; Costantino Iadecola; Thomas M Coffman
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

3.  Improved method for surgical induction of chronic hypertension in mice.

Authors:  Tom Skaria; Mostafa A Aboouf; Johannes Vogel
Journal:  Biol Open       Date:  2022-07-05       Impact factor: 2.643

4.  Nobiletin resolves left ventricular and renal changes in 2K-1C hypertensive rats.

Authors:  Metee Iampanichakul; Anuson Poasakate; Prapassorn Potue; Siwayu Rattanakanokchai; Putcharawipa Maneesai; Parichat Prachaney; Wannapa Settheetham-Ishida; Poungrat Pakdeechote
Journal:  Sci Rep       Date:  2022-06-03       Impact factor: 4.996

5.  Congestive heart failure: experimental model.

Authors:  Antonio Francesco Corno; Xue Cai; Caroline B Jones; Giuseppina Mondani; Mark R Boyett; Jonathan Charles Jarvis; George Hart
Journal:  Front Pediatr       Date:  2013-10-28       Impact factor: 3.418

6.  Occipital Artery Function during the Development of 2-Kidney, 1-Clip Hypertension in Rats.

Authors:  Stephen P Chelko; Chad W Schmiedt; Tristan H Lewis; Tom P Robertson; Stephen J Lewis
Journal:  Int J Vasc Med       Date:  2014-07-22

7.  Establishment and evaluation of a reversible two-kidney, one-clip renovascular hypertensive rat model.

Authors:  Li-Qiang Li; Jian Zhang; Rong Wang; Jian-Xin Li; Yong-Quan Gu
Journal:  Exp Ther Med       Date:  2017-04-26       Impact factor: 2.447

8.  Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy.

Authors:  Alex A Gutsol; Paula Blanco; Taben M Hale; Jean-Francois Thibodeau; Chet E Holterman; Rania Nasrallah; Jose W N Correa; Sergey A Afanasiev; Rhian M Touyz; Chris R J Kennedy; Dylan Burger; Richard L Hébert; Kevin D Burns
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

9.  Peperomia pellucida (L.) Kunth as an angiotensin-converting enzyme inhibitor in two-kidney, one-clip Goldblatt hypertensive rats.

Authors:  Fadlina Chany Saputri; Irma Hutahaean; Abdul Mun'im
Journal:  Saudi J Biol Sci       Date:  2021-06-30       Impact factor: 4.219

Review 10.  Mesenchymal Stem Cell-Derived Exosomes: Toward Cell-Free Therapeutic Strategies in Chronic Kidney Disease.

Authors:  Qinghua Cao; Chunling Huang; Xin-Ming Chen; Carol A Pollock
Journal:  Front Med (Lausanne)       Date:  2022-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.